Abstract:BACKGROUND: It is feasible to prepare the microsphere delivery system of protein and polypeptide drugs including insulin, by various proteolytic enzymes. This system may overcome such disadvantages as poor stability, short half-life time and the inactivation resuled in hydrolysis. OBJECTIVE: To construct an insulin controlled microcapsule, and to investigate its in vitro controlled release and in vivo hypoglycemic effect. DESIGN, TIME AND SETTING: A controlled observation experiment was performed in Nanomedicine and Biosensor Laboratory Bio-X Center, Harbin Institute of Technology between May 2007 and January 2008. MATERIALS: Male Wistar rats were used to establish diabetes mellitus models by the intraperitoneal injection of streptozotocin. An insulin controlled microcapsule was fabricated by layer-by-layer self-assembly of dextran sulphate and ferric ion via electrostatic interaction. METHODS: The release effect of insulin-loaded microcapsules was detected by in vitro test. Eighteen diabetes mellitus models were divided into three groups randomly, and received subcutaneous injections of insulin 5 U/kg, subcutaneous injections of insulin 100 U/kg, and intragastric administration of insulin-loaded microcapsules 100 U/kg, respectively. MAIN OUTCOME MEASURES: The encapsulation efficiency, drug loading content, in vitro release behavior and in vivo hypoglycemic effect of the insulin-loaded microcapsules were all assessed. RESULTS: The encapsulation efficiency and drug loading content of the insulin-loaded microcapsules were higher than 60% and 40%, respectively. The results of in vitro insulin releasing test displayed good release behavior, and drug release speed stepped down with the increase of encapsulation layers. The in vivo hypoglycemic effect study showed the insulin-loaded microcapsules significantly improved glucose tolerance to 6-10 hours by subcutaneous injection, while no effect was found after intragastric administration. CONCLUSION: Fabricated by layer-by-layer self-assembly of dextran sulphate and ferric ion via electrostatic interaction, the insulin-loaded microcapsules have a better stability, and could maintain the hypoglycemic effect for a long time.

Long-Acting Insulin-Zwitterionic Polymer Conjugate Mitigates Hypoglycemia.

Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery.

Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

An orally administered glucose-responsive polymeric complex for high-efficiency and safe delivery of insulin in mice and pigs

Glycopolymer Nanoparticles with On-Demand Glucose-Responsive Insulin Delivery and Low-Hypoglycemia Risks for Type 1 Diabetic Treatment

Lyophilized Insulin Micelles for Long-Term Storage and Regulation of Blood Glucose for Preventing Hypoglycemia

Long-term glycemic control and prevention of diabetes complications in vivo using oleic acid-grafted-chitosan‑zinc-insulin complexes incorporated in thermosensitive copolymer

A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles.

Injectable nanosized formulation for glucose-responsive insulin delivery

Week-long Normoglycaemia in Diabetic Mice and Minipigs Via a Subcutaneous Dose of a Glucose-Responsive Insulin Complex

Supramolecular Approaches for Insulin Stabilization Without Prolonged Duration of Action

Stable Monomeric Insulin Formulations Enabled by Supramolecular PEGylation of Insulin Analogues

Construction and functional evaluation of oral long-acting insulin hydrogel microparticles based on physical and chemical double crosslinking

Charge-switchable Polymeric Complex for Glucose-Responsive Insulin Delivery in Mice and Pigs

Injectable Gelled Multiple Emulsion for Glucose‐Responsive Insulin Delivery

Dually-crosslinked Degradable Polyionic Micelles for Sustained Glucose-responsive Insulin Release

Controlled release and hypoglycemic effect of insulin microcapsules constructed by dextran sulphate and ferricion

Beneficial Properties for Insulin Absorption Using Superporous Hydrogel Containing Interpenetrating Polymer Network As Oral Delivery Vehicles

Novel Iron-Polysaccharide Multilayered Microcapsules for Controlled Insulin Release

Functional Nanochaperones for PEGylated Insulin Delivery in Long-Term Glycemic Control

Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin